Matrix metalloproteinases

US6734005B2 · kind B2 · utility

Assignee

• Pharmacia & Upjohn Company LLC · US

Inventors

• Timothy E. Wood · Weare, US
• Jonas Ekblom · Uppsala, SE
• Erik Holmgren · Lidingö, SE
• Mats Kihlen · Uppsala, SE

Key dates

• Filing date: May 22, 2001
• Grant date: May 11, 2004
• Expiry date: Jul 15, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2799/021
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.